Xylazine is a New Threat That Demands Swift Action Using Lessons from the Past
The Rothman Orthopaedic Institute Foundation for Opioid Research and EducationOpinion piece on using opioid crisis as a blueprint for addressing Xylazine and F2 spread
Opinion piece on using opioid crisis as a blueprint for addressing Xylazine and F2 spread
Racial Differences in Opioid Use Disorder
Pennsylvania legislators and top medical experts will come together to address the growing xylazine crisis at an upcoming free symposium. The event, titled "The Next Chapter of the Opioid Epidemic in Pennsylvania: The Xylazine Crisis," will be held on November 23, 2024, at the Bluemle Life Science Building at Jefferson Med in Philadelphia.
The Rothman Orthopaedic Institute Foundation for Opioid Research & Education announces a symposium titled "The Next Chapter of the Opioid Epidemic in Pennsylvania: The Xylazine Crisis" to be held on November 23, 2024, from 8:30 am to 12:30 pm at the Bluemle Life Science Building at Jefferson Med in Philadelphia.
A recent study reveals a troubling surge in opioid-related deaths across the Appalachian region, with rural areas suffering the highest rates.
In 2016, nearly 2 million opioid prescriptions were given to patients across the state. However, by the end of the study period in 2020, there was a 38 percent decrease in opioid prescriptions written, according to this study by Dr. Asif Ilyas.
In light of the national opioid crisis, a recent study by researchers at the Rothman Orthopaedic Institute and its Department of Medical Cannabis explores the use of medical cannabis (MC) as a potential alternative for chronic pain management.
Results of a study shows the opioid crisis is not just about the drugs used; it is also about the ones that are not used. The findings, emphasizing the importance of safe drug disposal, are timely as the next National Prescription Drug Take Back Day, sponsored by the US Drug Enforcement Agency (DEA), approaches on April 27, 2024.
Physician assistants (PAs) and nurse practitioners (NPs) are at the heart of patient care in Appalachia, often taking the lead in managing pain and prescribing medications. Their role is significant, but their training in opioid management falls short when compared to their physician counterparts.
A Philadelphia-based non-profit foundation is combating the opioid addiction epidemic at the source by educating frontline allied health professionals on various aspects of the nation's opioid crisis, specifically in Pennsylvania and the Appalachian region.